Glutamate: a new target in schizophrenia?
- 30 June 1990
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 11 (6), 219-220
- https://doi.org/10.1016/0165-6147(90)90243-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989
- Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related DrugsScience, 1989
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987
- Quantitative Cytoarchitectural Studies of the Cerebral Cortex of SchizophrenicsArchives of General Psychiatry, 1986
- The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartateBritish Journal of Pharmacology, 1983
- Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in micePsychopharmacology, 1980
- PhencyclidineNature, 1980
- Phencyclidine-induced psychosisAmerican Journal of Psychiatry, 1978
- The Dopamine Hypothesis of Schizophrenia: A Review*Schizophrenia Bulletin, 1976